XML 53 R17.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stockholders' Equity
 12 Months Ended
Dec. 31, 2013
Stockholders' Equity

(11) STOCKHOLDERS’ EQUITY

In March 2012, the Company issued 266,478 shares of restricted common stock of the Company valued at $158 related to its acquisition of NeuroDyne.  During 2012, 34,500 shares of common stock were issued for cash of $13, upon the exercise of stock options, 5,625 shares of common stock were issued upon the cashless exercise of 50,000 non-employee warrants, and    25,000  shares of common stock were issued to individuals as non-cash compensation for services rendered, valued at approximately $20  (based on the market price of the Company’s common stock on the date of the grants).

On November 1, 2013, an employee entered into a separation agreement with the Company that, among other things, converted 46,000 common stock options into 23,000 common shares at a cashless exercise price of $0.50 per share. (Note 15)

For stock warrants or options granted to non-employees, the Company measures fair value of the equity instruments utilizing the Black-Scholes method if that valuation method results in a more reliable measurement than the fair value of the consideration or the services received. For stock granted, the Company measures fair value of the shares issued utilizing the market price of the shares on the date the transaction takes place. The Company amortizes such costs over the related period of service.